The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Immunoglobulin A Nephropathy: 5 Treatment Approaches to Know

The treatment landscape for IgA nephropathy is rapidly evolving, with therapies focused on mitigating the effects of nephron loss now being combined with immunomodulatory treatments.

Tolvaptan vs Fluid Limits: Do Costs Outweigh pNa Gains?

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection of sodium increases.

Outpatient RSV in Kids Younger Than 2 Has Distinct Features

In outpatient care, RSV infections in children younger than 2 years present with distinct clinical features and greater illness burden than infections caused by other respiratory viruses.

Pfizer's Eczema Drug Meets Main Goal in Mid-stage Trial, Plans Late-stage Study

U.S. drugmaker Pfizer said on Monday its experimental drug for a ⁠chronic skin disease met the main goal in a mid-stage study.

Gene Therapy Injections for Knee OA: Where Are We At?

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

Women at Higher Risk for Chronic Cough With Age

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing with age.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

The treatment landscape for IgA nephropathy is rapidly evolving, with therapies focused on mitigating the effects of nephron loss now being combined with immunomodulatory treatments.

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection of sodium increases.

In outpatient care, RSV infections in children younger than 2 years present with distinct clinical features and greater illness burden than infections caused by other respiratory viruses.

U.S. drugmaker Pfizer said on Monday its experimental drug for a ⁠chronic skin disease met the main goal in a mid-stage study.

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing with age.

News All Time

New Model Predicts In-Hospital Death in Acute Liver Failure

A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with acute liver failure and reveals top risk drivers.

Verekitug Improved Chronic Rhinosinusitis With Nasal Polyps

Adverse events were similar between the groups, with more high-grade events occurring in the placebo group.

Rituximab Cuts ANCA Vasculitis Pneumococcal Vaccine Response

‘These data indicate that either alternative vaccine strategies or alternative strategies to protect these patients from pneumococcal disease are required,’ said Michael Chen-Xu, MD.

Can We Predict Relapse, Drug Response in Renal Vasculitis?

Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors best predict relapse in patients with the kidney disease.

Chronic Rhinosinusitis Tied to Increased Cancer Risk

Results from Asia suggest chronic rhinosinusitis is associated with an increased risk for cancer, but whether these results apply to the US population remains uncertain.

New Hereditary Angioedema Drug Navenibart Safe, Effective

Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.

European Food Safety Authority Flags Cannabidiol Safety Gaps

European Food Safety Authority sets a provisional safe intake for cannabidiol at 0.0275 mg/kg per day, or about 2 mg/d for a 70 kg adult.

Subunit RSV Vaccine Recommended for Adults Older Than 75

The protein subunit vaccines reduced hospitalizations for one season and severe illness for two seasons.

Early Neonatal Infection Linked to Cognitive Risk Later

Early-onset neonatal infection is linked to higher risks for intellectual disability and special educational needs during childhood, with meningitis carrying a higher risk than sepsis.

ELISA Test Fares Best for Identifying ABPA

A small percentage of samples from possible cases meet serologic criteria for infection.

Prolonged Amoxicillin Challenge Checks Penicillin Allergy

A 5-day amoxicillin challenge is feasible for evaluating delayed penicillin allergy, a new study shows.

Fix Mold, Reduce Asthma ED Visits?

New York City’s Mold Busters program is associated with thousands fewer emergency department visits for asthma per year, research shows.

Family History of Kidney Failure Tied to CKD Progression

In patients with chronic kidney disease, a family history of kidney failure may raise the risk for disease progression, even after accounting for individual genetic risk and social factors.

Managing Resistant Hypertension Is Like Playing Chess

Managing resistant hypertension requires looking two moves ahead. Dr Chuck Vega discusses edema, hypokalemia, and the surprising renal benefits of MRAs.

AI Finds Three Predictive Variants for Postoperative Sepsis

A genome-wide AI model prioritizes three genetic variants linked to postoperative sepsis and outlines how preoperative genotyping could support targeted monitoring strategies.

Are Italian Doctors Being Punished for Compassion?

The case of six Italian physicians accused of falsifying detention fitness certificates has ignited debate over science, conscience, and politics.

Recommended News For You

New analysis helps discern benign from malignant thyroid growths

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

A US health panel advises starting mammograms at age 40 rather than 50.

Health researchers discuss Medicaid cancer screening trends, best practices

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

Recommended Articles For You

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates 

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A video animation guide to assist young people who are fatigued from cancer.

2.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

3.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

4.

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

5.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

1.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

2.

Unlocking the Immune Arsenal: A Revolution in Cancer Treatment

3.

Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options 

4.

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer

5.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

4.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot